These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 505418)

  • 1. Coagulation activity of surface activated plasma in vivo.
    Swedenborg J; Kourias E; Olsson P
    Thromb Res; 1979; 16(1-2):231-7. PubMed ID: 505418
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of total factor XII and of activated factor XII in plasma with a chromogenic substrate.
    Vinazzer H
    Thromb Res; 1979 Jan; 14(1):155-66. PubMed ID: 425078
    [No Abstract]   [Full Text] [Related]  

  • 3. Cofactor of the "lupus anticoagulant".
    Rivard GE; Schiffman S; Rapaport SI
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):554-63. PubMed ID: 4141516
    [No Abstract]   [Full Text] [Related]  

  • 4. The procoagulant activity of granulocytes.
    Saba HI; Herion JC; Walker RI; Roberts HR
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):614-20. PubMed ID: 4689394
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the coagulation factors from V through XIII].
    Yoshida K; Tagawa N
    Nihon Rinsho; 1973 Apr; 31(4):755-64. PubMed ID: 4580392
    [No Abstract]   [Full Text] [Related]  

  • 6. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.
    Walsh PN; Griffin JH
    Blood; 1981 Jan; 57(1):106-18. PubMed ID: 7004531
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of chronic administration of lathyrogen (beta-aminopropionitrile) on blood clotting and fibrinolytic system in rabbits.
    Bańkowski E; Worowski K
    Thromb Diath Haemorrh; 1969 Nov; 22(2):372-6. PubMed ID: 5380956
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion support for congenital clotting deficiencies other than haemophilia.
    Lewis JH; Spero JA; Ragni MV; Bontempo FA
    Clin Haematol; 1984 Feb; 13(1):119-35. PubMed ID: 6609789
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.
    Goodnough LT; Saito H; Ratnoff OD
    Medicine (Baltimore); 1983 Jul; 62(4):248-55. PubMed ID: 6348471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency.
    Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
    Blood; 1984 May; 63(5):1004-14. PubMed ID: 6713090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of procoagulant (tissue thromboplastin) activity in cultured leukocytes.
    Kociba GJ; Loeb WF; Wall RL
    J Lab Clin Med; 1972 May; 79(5):778-87. PubMed ID: 5018741
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory diagnosis of congenital coagulation defects.
    Lowe GD; Forbes CD
    Clin Haematol; 1979 Feb; 8(1):79-94. PubMed ID: 310747
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of salivary tissue factor (thromboplastin) activity by warfarin therapy.
    Zacharski LR; Rosenstein R
    Blood; 1979 Mar; 53(3):366-74. PubMed ID: 760859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental models of human congenital coagulation defects].
    Kase F
    Probl Gematol Pereliv Krovi; 1981 Nov; 26(11):41-4. PubMed ID: 7033960
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency.
    Miller GJ; Martin JC; Mitropoulos KA; Esnouf MP; Cooper JA; Morrissey JH; Howarth DJ; Tuddenham EG
    Blood; 1996 May; 87(10):4187-96. PubMed ID: 8639777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of human leukocyte thromboplastic activity by endotoxin.
    Lerner RG; Goldstein R; Cummings G; Lange K
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):145-8. PubMed ID: 4942184
    [No Abstract]   [Full Text] [Related]  

  • 17. Some effects of a microcrystalline collagen preparation on blood.
    Mason RG; Read MS
    Haemostasis; 1974; 3(1):31-45. PubMed ID: 4215704
    [No Abstract]   [Full Text] [Related]  

  • 18. Prothrombin utilization in congenital coagulation deficiency states.
    Owen CA; Thompson JH
    Thromb Diath Haemorrh; 1971 Jun; 25(2):297-311. PubMed ID: 5568049
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitor of human blood coagulation elicited by thrombin.
    Marciniak E
    J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
    [No Abstract]   [Full Text] [Related]  

  • 20. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.
    Pineo GF; Regoeczi E; Hatton MW; Brain MC
    J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.